AXA: Credit Suisse raises target price.
(CercleFinance.com) - In a research report issued on Tuesday morning, Credit Suisse has raised its target price on AXA from 27.
5 euros to 28 euros, while renewing its "outperform" rating.
The Swiss broker reacted to the insurer's high-quality interim results, and considers the IPO in the US as a strategically important transaction, which could be a positive catalyst for the share.
Furthermore, it also raised its estimates by between 2% and 4% over the period 2017/2020. According to Credit Suisse, the group's earnings trajectory is still likely to exceed expectations.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
5 euros to 28 euros, while renewing its "outperform" rating.
The Swiss broker reacted to the insurer's high-quality interim results, and considers the IPO in the US as a strategically important transaction, which could be a positive catalyst for the share.
Furthermore, it also raised its estimates by between 2% and 4% over the period 2017/2020. According to Credit Suisse, the group's earnings trajectory is still likely to exceed expectations.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.